Nicotine 21 mg/24h (Nicotine PATCH) 21 mg/24h

Nicotine 21 mg/24h patches aid in smoking cessation by delivering controlled doses of nicotine through the skin. These transdermal patches are designed to help reduce withdrawal symptoms and cravings.

Strength

21 mg/24h

Pack Size

7 POUCH in 1 CARTON (0536-5896-53) / 1 h in 1 POUCH

Manufacturer / TM Owner

Rugby Laboratories

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nicotine patches are primarily used to help individuals quit smoking by providing a steady release of nicotine. They are often part of a comprehensive smoking cessation plan, helping to manage withdrawal symptoms and cravings. Nicotine patches can be used as directed by a healthcare professional to support smoking cessation efforts.

Side Effects

Nicotine patches work by delivering nicotine through the skin, which can help reduce the urge to smoke. Common effects may include skin irritation at the application site. Some users may experience mild side effects such as headaches or dizziness.

Precautions & Warnings

Nicotine patches should be used as directed and stored properly to maintain their effectiveness. Avoid applying the patch to broken or irritated skin. It is important to follow the instructions provided by the healthcare professional or the product packaging.

Avoid Interactions

Nicotine patches may interact with certain medications, including those metabolized by the liver. It is advisable to consult a healthcare professional before using nicotine patches if you are taking other medications. Additionally, avoid using nicotine patches in combination with other nicotine products.

Frequently Asked Questions

Nicotine 21 mg/24h patches are used to help individuals quit smoking by providing a controlled release of nicotine through the skin.

Nicotine patches deliver nicotine through the skin, helping to reduce withdrawal symptoms and cravings associated with quitting smoking.

Common side effects of nicotine patches may include skin irritation, headaches, or dizziness. Always follow the instructions provided.

Nicotine patches should be stored in a cool, dry place, away from direct sunlight and heat sources.

It is advisable to consult a healthcare professional before using nicotine patches if you are taking other medications to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.